secwatch.observer — SEC 8-K summary
======================================

Issuer:     PharmaCyte Biotech, Inc. (PMCB)
CIK:        0001157075
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001683168-23-007830
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 4.01
LLM model:  deepseek-v4-flash:cloud@v2

PharmaCyte Biotech engages Marcum LLP as new independent auditor after Armanino resignation
--------------------------------------------------------------------------------

- Armanino resigned as independent auditor on August 1, 2023, citing exit from public company audit practice.
- Marcum LLP was engaged as new independent registered public accounting firm on November 5, 2023.
- No disagreements or reportable events occurred with Armanino during the past two fiscal years or subsequent period.
- Company had not consulted Marcum on accounting principles or audit opinions prior to engagement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157075/000168316823007830/0001683168-23-007830-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157075/000168316823007830/pharmacyte_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-007830

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer